10 Healthcare Focused Hedge Funds and 10 Top Stock Picks
In this article, we discuss 10 healthcare focused hedge funds and 10 top stock picks.
Hedge Fund - OrbiMed Advisors
News, Interviews, and Investor Letters
- 1 - 10
- Next >>
Top 5 Stocks Activist Investors Are Targeting
Next in line in our list of top 10 stocks activist investors are targeting is another healthcare company in which RA Capital increased its position.
Hedge Fund and Insider Trading News: Paul Tudor Jones, Boaz Weinstein, Bill Ackman, DG Partners, OrbiMed Advisors, Twilio Inc (TWLO), Aritzia Inc (ATZAF), and More
Legendary hedge fund manager Paul Tudor Jones said Thursday that he expects a Democratic sweep in November and that will send markets for a wild ride over the next 12 months.
13D Filing: OrbiMed Advisors and Adaptimmune Therapeutics PLC - ADR (ADAP)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...
13D Filing: OrbiMed Advisors and Corvus Pharmaceuticals Inc (CRVS)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...
13D Filing: OrbiMed Advisors and Viewray Inc. (VRAY)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...
13D Filing: OrbiMed Advisors and Pieris Pharmaceuticals Inc. (PIRS)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...
13D Filing: OrbiMed Advisors and Nabriva Therapeutics PLC - ADR (NBRV)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...
13D Filing: OrbiMed Advisors and Pieris Pharmaceuticals Inc. (PIRS)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...
13D Filing: OrbiMed Advisors and Alpine Immune Sciences Inc. (ALPN)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d‑1(e), 240....
- 1 - 10
- Next >>